melatonin has been researched along with Cardiac Failure in 26 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin, the major secretion of the pineal gland, has beneficial effects on the cardiovascular system and might advantage heart failure with reduced ejection fraction (HFrEF) by attenuating the effects of the renin-angiotensin-aldosterone and sympathetic system on the heart besides its antioxidant and anti-inflammatory effects." | 9.51 | Melatonin supplementation improves N-terminal pro-B-type natriuretic peptide levels and quality of life in patients with heart failure with reduced ejection fraction: Results from MeHR trial, a randomized clinical trial. ( Azizi, E; Garakyaraghi, M; Heshmat-Ghahdarijani, K; Hoseini, SG; Khosrawi, S; Mansourian, M; Roohafza, H; Sadeghi, M; Shafie, D, 2022) |
| "The current study (clinical trial registered number: CHWX-904-201511) suggests that acute melatonin treatment can reduce the incidence of delirium for elderly acute heart failure." | 9.51 | Effects of Melatonin for Delirium in Elderly Acute Heart Failure Patients: A Randomized, Single-Center, Double-Blind, and Placebo-Controlled Trial. ( Gu, L; Liu, X; Wan, R; Ye, T; Yin, B; Zong, G, 2022) |
| "This study aimed to investigate the effect of melatonin supplementation on endothelial function in patients with heart failure with reduced ejection fraction (HFrEF)." | 9.41 | Effect of melatonin supplementation on endothelial function in heart failure with reduced ejection fraction: A randomized, double-blinded clinical trial. ( Azizi, E; Garakyaraghi, M; Gheisari, Y; Heshmat-Ghahdarijani, K; Hoseini, SG; Khosrawi, S; Mansourian, M; Roohafza, H; Sadeghi, M; Shafie, D, 2021) |
| "Current studies indicate that melatonin can counteract renin-angiotensin-aldosterone system and sympathetic over activity in heart failure (HF) and might have a protective and repairing effect on cardiovascular injuries, skeletal muscle weakness, and metabolic abnormalities, which are common pathological processes in patients with HF." | 9.34 | Effect of melatonin on heart failure: design for a double-blinded randomized clinical trial. ( Gheisari, Y; Heshmat-Ghahdarijani, K; Hoseini, SG; Khosrawi, S; Mansoorian, M; Roohafza, H; Sadeghi, M, 2020) |
| "Melatonin has been shown to inhibit myocardial infarction-induced apoptosis, its function in heart failure with preserved ejection fraction (HFpEF) has not been investigated." | 7.88 | Melatonin improves cardiac function in a mouse model of heart failure with preserved ejection fraction. ( Dong, JZ; Gao, L; Guo, S; Li, L; Li, LN; Liang, C; Liu, Y; Liu, YZ; Tu, S; Wang, D; Yang, HB; Zhao, XY, 2018) |
| "To assess the significance of melatonin, NT-proBNP and morphological markers of myocardial remodeling for predicting the risk of complications after coronary artery bypass grafting (CABG) in patients with ischemic heart disease and chronic heart failure (CHF)." | 7.85 | [Prognostic Value of Melatonin Level, Structural and Functional Changes of the Myocardium in the Development of Complications in Patients With Heart Failure who Underwent Coronary Artery Bypass Grafting: the Possibilities of Pharmacological Cardioprotecti ( Avchenko, GM; Erkhov, AY; Liskova, YV; Popov, AB; Rozhkov, VO; Salikova, SP; Selivanov, SA; Stadnikov, AA; Tverdokhlib, NB, 2017) |
| " This study investigated whether melatonin prevents LV remodeling and improves survival in isoproterenol-induced heart failure." | 7.80 | Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure. ( Adamcova, M; Bednarova, KR; Celec, P; Gajdosechova, L; Hrenak, J; Kamodyova, N; Krajcirovicova, K; Simko, F; Zorad, S, 2014) |
| "The aim of the study was to examine the reorganization of extracellular matrix left ventricular myocardium (LVM) rats (n = 38) with experimental heart failure (EHF) as affected by perindopril and melatonin administration." | 7.80 | [Extracellular matrix remodeling myocardium of the left ventricle rats with experimental heart failure after perindopril and melatonin administration]. ( Liskova, IuV; Salikova, SP; Stadnikov, AA, 2014) |
| "Assessment of the alteration in diurnal and nocturnal melatonin serum levels in patients with chronic heart failure." | 7.79 | Alteration in diurnal and nocturnal melatonin serum level in patients with chronic heart failure. ( Dzida, G; Hałabiś, M; Kadas, T; Kamieński, P; Kiciński, P; Kimak, E; Lachowska-Kotowska, P; Prystupa, A, 2013) |
| "The aim of the study was to examine the reorganization of left ventricular myocardium (LVM) in ovariectomized rats with experimental heart failure (EHF) as affected by melatonin administration." | 7.79 | [Structural reorganization of the myocardium in ovariectomized rats with experimental heart failure after melatonin administration]. ( Liskova, IuV; Salikova, SP; Stadnikov, AA, 2013) |
| "To assess urinary 6-sulfatoxymelatonin excretion in patients admitted to the hospital because of congestive heart failure (CHF)." | 7.72 | Low urinary 6-sulfatoxymelatonin levels in patients with severe congestive heart failure. ( Albornoz, LE; Cardinali, DP; Dini, A; Elizari, MV; Girotti, L; Ianovsky, O; Lago, M; Pérez Lloret, S, 2003) |
| "Melatonin plays a crucial role in major pathological processes associated with heart failure including ischemic injury, oxidative stress, apoptosis, and cardiac remodeling." | 6.58 | Melatonin in Heart Failure: A Promising Therapeutic Strategy? ( Maarman, GJ; Nduhirabandi, F, 2018) |
| "Melatonin treatment for 8 weeks markedly attenuated cardiac hypertrophy and restored impaired cardiac function, as indicated by a decreased HW/BW ratio, reduced cell cross-sectional area and fibrosis, downregulated the mRNA levels of ANP, BNP, and β-MHC and ameliorated adverse effects on the LVEF and LVFS." | 5.56 | Melatonin ameliorates pressure overload-induced cardiac hypertrophy by attenuating Atg5-dependent autophagy and activating the Akt/mTOR pathway. ( Ding, P; Fan, ZG; Gao, EH; Kong, LH; Liu, Y; Xu, CN; Yang, J; Yang, LF, 2020) |
| "Melatonin, the major secretion of the pineal gland, has beneficial effects on the cardiovascular system and might advantage heart failure with reduced ejection fraction (HFrEF) by attenuating the effects of the renin-angiotensin-aldosterone and sympathetic system on the heart besides its antioxidant and anti-inflammatory effects." | 5.51 | Melatonin supplementation improves N-terminal pro-B-type natriuretic peptide levels and quality of life in patients with heart failure with reduced ejection fraction: Results from MeHR trial, a randomized clinical trial. ( Azizi, E; Garakyaraghi, M; Heshmat-Ghahdarijani, K; Hoseini, SG; Khosrawi, S; Mansourian, M; Roohafza, H; Sadeghi, M; Shafie, D, 2022) |
| "The current study (clinical trial registered number: CHWX-904-201511) suggests that acute melatonin treatment can reduce the incidence of delirium for elderly acute heart failure." | 5.51 | Effects of Melatonin for Delirium in Elderly Acute Heart Failure Patients: A Randomized, Single-Center, Double-Blind, and Placebo-Controlled Trial. ( Gu, L; Liu, X; Wan, R; Ye, T; Yin, B; Zong, G, 2022) |
| " A histological analysis revealed that chronic intake of MEL diminished the age-dependent changes in the structure of muscle fibers of the left ventricle, muscle fiber swelling, and injury zones characteristic of acute cardiac failure caused by ISO." | 5.48 | Effect of Melatonin on Rat Heart Mitochondria in Acute Heart Failure in Aged Rats. ( Akatov, V; Baburina, Y; Fadeeva, I; Krestinina, O; Kruglov, A; Odinokova, I; Sotnikova, L; Zvyagina, A, 2018) |
| "Melatonin is a secretory product of the pineal gland with highly beneficial effects from any tissues including the heart." | 5.43 | Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony. ( Abreu-Gonzalez, P; Dominguez-Rodriguez, A; Galasso, G; Piccolo, R; Reiter, RJ, 2016) |
| "This study aimed to investigate the effect of melatonin supplementation on endothelial function in patients with heart failure with reduced ejection fraction (HFrEF)." | 5.41 | Effect of melatonin supplementation on endothelial function in heart failure with reduced ejection fraction: A randomized, double-blinded clinical trial. ( Azizi, E; Garakyaraghi, M; Gheisari, Y; Heshmat-Ghahdarijani, K; Hoseini, SG; Khosrawi, S; Mansourian, M; Roohafza, H; Sadeghi, M; Shafie, D, 2021) |
| "Current studies indicate that melatonin can counteract renin-angiotensin-aldosterone system and sympathetic over activity in heart failure (HF) and might have a protective and repairing effect on cardiovascular injuries, skeletal muscle weakness, and metabolic abnormalities, which are common pathological processes in patients with HF." | 5.34 | Effect of melatonin on heart failure: design for a double-blinded randomized clinical trial. ( Gheisari, Y; Heshmat-Ghahdarijani, K; Hoseini, SG; Khosrawi, S; Mansoorian, M; Roohafza, H; Sadeghi, M, 2020) |
| "Melatonin has been shown to inhibit myocardial infarction-induced apoptosis, its function in heart failure with preserved ejection fraction (HFpEF) has not been investigated." | 3.88 | Melatonin improves cardiac function in a mouse model of heart failure with preserved ejection fraction. ( Dong, JZ; Gao, L; Guo, S; Li, L; Li, LN; Liang, C; Liu, Y; Liu, YZ; Tu, S; Wang, D; Yang, HB; Zhao, XY, 2018) |
| "To assess the significance of melatonin, NT-proBNP and morphological markers of myocardial remodeling for predicting the risk of complications after coronary artery bypass grafting (CABG) in patients with ischemic heart disease and chronic heart failure (CHF)." | 3.85 | [Prognostic Value of Melatonin Level, Structural and Functional Changes of the Myocardium in the Development of Complications in Patients With Heart Failure who Underwent Coronary Artery Bypass Grafting: the Possibilities of Pharmacological Cardioprotecti ( Avchenko, GM; Erkhov, AY; Liskova, YV; Popov, AB; Rozhkov, VO; Salikova, SP; Selivanov, SA; Stadnikov, AA; Tverdokhlib, NB, 2017) |
| " This study investigated whether melatonin prevents LV remodeling and improves survival in isoproterenol-induced heart failure." | 3.80 | Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure. ( Adamcova, M; Bednarova, KR; Celec, P; Gajdosechova, L; Hrenak, J; Kamodyova, N; Krajcirovicova, K; Simko, F; Zorad, S, 2014) |
| "The aim of the study was to examine the reorganization of extracellular matrix left ventricular myocardium (LVM) rats (n = 38) with experimental heart failure (EHF) as affected by perindopril and melatonin administration." | 3.80 | [Extracellular matrix remodeling myocardium of the left ventricle rats with experimental heart failure after perindopril and melatonin administration]. ( Liskova, IuV; Salikova, SP; Stadnikov, AA, 2014) |
| "Assessment of the alteration in diurnal and nocturnal melatonin serum levels in patients with chronic heart failure." | 3.79 | Alteration in diurnal and nocturnal melatonin serum level in patients with chronic heart failure. ( Dzida, G; Hałabiś, M; Kadas, T; Kamieński, P; Kiciński, P; Kimak, E; Lachowska-Kotowska, P; Prystupa, A, 2013) |
| "The aim of the study was to examine the reorganization of left ventricular myocardium (LVM) in ovariectomized rats with experimental heart failure (EHF) as affected by melatonin administration." | 3.79 | [Structural reorganization of the myocardium in ovariectomized rats with experimental heart failure after melatonin administration]. ( Liskova, IuV; Salikova, SP; Stadnikov, AA, 2013) |
| "To assess urinary 6-sulfatoxymelatonin excretion in patients admitted to the hospital because of congestive heart failure (CHF)." | 3.72 | Low urinary 6-sulfatoxymelatonin levels in patients with severe congestive heart failure. ( Albornoz, LE; Cardinali, DP; Dini, A; Elizari, MV; Girotti, L; Ianovsky, O; Lago, M; Pérez Lloret, S, 2003) |
| "Melatonin plays a crucial role in major pathological processes associated with heart failure including ischemic injury, oxidative stress, apoptosis, and cardiac remodeling." | 2.58 | Melatonin in Heart Failure: A Promising Therapeutic Strategy? ( Maarman, GJ; Nduhirabandi, F, 2018) |
| "Melatonin treatment for 8 weeks markedly attenuated cardiac hypertrophy and restored impaired cardiac function, as indicated by a decreased HW/BW ratio, reduced cell cross-sectional area and fibrosis, downregulated the mRNA levels of ANP, BNP, and β-MHC and ameliorated adverse effects on the LVEF and LVFS." | 1.56 | Melatonin ameliorates pressure overload-induced cardiac hypertrophy by attenuating Atg5-dependent autophagy and activating the Akt/mTOR pathway. ( Ding, P; Fan, ZG; Gao, EH; Kong, LH; Liu, Y; Xu, CN; Yang, J; Yang, LF, 2020) |
| " A histological analysis revealed that chronic intake of MEL diminished the age-dependent changes in the structure of muscle fibers of the left ventricle, muscle fiber swelling, and injury zones characteristic of acute cardiac failure caused by ISO." | 1.48 | Effect of Melatonin on Rat Heart Mitochondria in Acute Heart Failure in Aged Rats. ( Akatov, V; Baburina, Y; Fadeeva, I; Krestinina, O; Kruglov, A; Odinokova, I; Sotnikova, L; Zvyagina, A, 2018) |
| "Melatonin is a secretory product of the pineal gland with highly beneficial effects from any tissues including the heart." | 1.43 | Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony. ( Abreu-Gonzalez, P; Dominguez-Rodriguez, A; Galasso, G; Piccolo, R; Reiter, RJ, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 2 (7.69) | 18.2507 |
| 2000's | 4 (15.38) | 29.6817 |
| 2010's | 11 (42.31) | 24.3611 |
| 2020's | 8 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Hoseini, SG | 3 |
| Heshmat-Ghahdarijani, K | 3 |
| Khosrawi, S | 3 |
| Garakyaraghi, M | 2 |
| Shafie, D | 2 |
| Mansourian, M | 2 |
| Roohafza, H | 3 |
| Azizi, E | 2 |
| Sadeghi, M | 3 |
| Yin, B | 1 |
| Ye, T | 1 |
| Liu, X | 1 |
| Wan, R | 1 |
| Gu, L | 1 |
| Zong, G | 1 |
| Crnko, S | 1 |
| Printezi, MI | 1 |
| Zwetsloot, PM | 1 |
| Leiteris, L | 1 |
| Lumley, AI | 1 |
| Zhang, L | 1 |
| Ernens, I | 1 |
| Jansen, TPJ | 1 |
| Homsma, L | 1 |
| Feyen, D | 1 |
| van Faassen, M | 1 |
| du Pré, BC | 1 |
| Gaillard, CAJM | 1 |
| Kemperman, H | 1 |
| Oerlemans, MIFJ | 1 |
| Doevendans, PAFM | 1 |
| May, AM | 1 |
| Zuithoff, NPA | 1 |
| Sluijter, JPG | 1 |
| Devaux, Y | 1 |
| van Laake, LW | 1 |
| Thonusin, C | 1 |
| Nawara, W | 1 |
| Arinno, A | 1 |
| Khuanjing, T | 1 |
| Prathumsup, N | 1 |
| Ongnok, B | 1 |
| Chattipakorn, SC | 1 |
| Chattipakorn, N | 1 |
| Davis, H | 1 |
| Attwell, D | 1 |
| Xu, CN | 1 |
| Kong, LH | 1 |
| Ding, P | 1 |
| Liu, Y | 2 |
| Fan, ZG | 1 |
| Gao, EH | 1 |
| Yang, J | 1 |
| Yang, LF | 1 |
| Gheisari, Y | 2 |
| Mansoorian, M | 1 |
| Salikova, SP | 3 |
| Liskova, YV | 1 |
| Stadnikov, AA | 3 |
| Selivanov, SA | 1 |
| Tverdokhlib, NB | 1 |
| Rozhkov, VO | 1 |
| Avchenko, GM | 1 |
| Erkhov, AY | 1 |
| Popov, AB | 1 |
| Odinokova, I | 1 |
| Baburina, Y | 1 |
| Kruglov, A | 1 |
| Fadeeva, I | 1 |
| Zvyagina, A | 1 |
| Sotnikova, L | 1 |
| Akatov, V | 1 |
| Krestinina, O | 1 |
| Li, LN | 1 |
| Guo, S | 1 |
| Zhao, XY | 1 |
| Liu, YZ | 1 |
| Liang, C | 1 |
| Tu, S | 1 |
| Wang, D | 1 |
| Li, L | 1 |
| Dong, JZ | 1 |
| Gao, L | 1 |
| Yang, HB | 1 |
| Nduhirabandi, F | 1 |
| Maarman, GJ | 1 |
| Şehirli, AÖ | 1 |
| Koyun, D | 1 |
| Tetik, Ş | 1 |
| Özsavcı, D | 1 |
| Yiğiner, Ö | 1 |
| Çetinel, Ş | 1 |
| Tok, OE | 1 |
| Kaya, Z | 1 |
| Akkiprik, M | 1 |
| Kılıç, E | 1 |
| Şener, G | 1 |
| Dzida, G | 1 |
| Prystupa, A | 1 |
| Lachowska-Kotowska, P | 1 |
| Kadas, T | 1 |
| Kamieński, P | 1 |
| Kimak, E | 1 |
| Hałabiś, M | 1 |
| Kiciński, P | 1 |
| Liskova, IuV | 2 |
| Dominguez-Rodriguez, A | 2 |
| Abreu-Gonzalez, P | 2 |
| Reiter, RJ | 2 |
| Simko, F | 1 |
| Bednarova, KR | 1 |
| Krajcirovicova, K | 1 |
| Hrenak, J | 1 |
| Celec, P | 1 |
| Kamodyova, N | 1 |
| Gajdosechova, L | 1 |
| Zorad, S | 1 |
| Adamcova, M | 1 |
| Piccolo, R | 1 |
| Galasso, G | 1 |
| Chen, LG | 1 |
| Qu, Y | 1 |
| Xiao, J | 1 |
| Guo, HL | 1 |
| Wan, CM | 1 |
| Wang, ZR | 1 |
| Girotti, L | 1 |
| Lago, M | 1 |
| Ianovsky, O | 1 |
| Elizari, MV | 1 |
| Dini, A | 1 |
| Pérez Lloret, S | 1 |
| Albornoz, LE | 1 |
| Cardinali, DP | 1 |
| Lisitsa, GV | 1 |
| Zaslavskaia, RM | 1 |
| Kalinina, EV | 1 |
| Scheer, FA | 1 |
| Stone, PH | 1 |
| Shea, SA | 1 |
| Natelson, BH | 1 |
| Ottenweller, JE | 1 |
| Tapp, WN | 1 |
| Heung, S | 1 |
| Beldowicz, D | 1 |
| Morishima, I | 1 |
| Matsui, H | 1 |
| Mukawa, H | 1 |
| Hayashi, K | 1 |
| Toki, Y | 1 |
| Okumura, K | 1 |
| Ito, T | 1 |
| Hayakawa, T | 1 |
| Malaia, LT | 1 |
| Rachinskiĭ, ID | 1 |
| Shushliapin, OI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Association Between Plasma Melatonin and No-reflow[NCT03306303] | 1,700 participants (Actual) | Observational | 2014-01-01 | Completed | |||
| A Triple Blinded Randomized Controlled Trial of Oral Melatonin in Elevated Blood Pressure Individual (MRCTEBP)[NCT03764020] | Phase 3 | 320 participants (Anticipated) | Interventional | 2019-06-01 | Not yet recruiting | ||
| Restoration of Sleep in Heart Failure Patients[NCT00869869] | Phase 2 | 0 participants (Actual) | Interventional | 2009-03-31 | Withdrawn (stopped due to No subjects were enrolled in this study. Funding ran out.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for melatonin and Cardiac Failure
| Article | Year |
|---|---|
Melatonin in Heart Failure: A Promising Therapeutic Strategy?
Topics: Animals; Fibrosis; Heart Failure; Humans; Hypertension; Melatonin | 2018 |
5 trials available for melatonin and Cardiac Failure
| Article | Year |
|---|---|
Melatonin supplementation improves N-terminal pro-B-type natriuretic peptide levels and quality of life in patients with heart failure with reduced ejection fraction: Results from MeHR trial, a randomized clinical trial.
Topics: Dietary Supplements; Heart Failure; Humans; Melatonin; Natriuretic Peptide, Brain; Peptide Fragments | 2022 |
Effects of Melatonin for Delirium in Elderly Acute Heart Failure Patients: A Randomized, Single-Center, Double-Blind, and Placebo-Controlled Trial.
Topics: Aged; Delirium; Double-Blind Method; Heart Failure; Humans; Length of Stay; Melatonin; Treatment Out | 2022 |
Effect of melatonin on heart failure: design for a double-blinded randomized clinical trial.
Topics: Double-Blind Method; Heart Failure; Hospitalization; Humans; Melatonin; Quality of Life | 2020 |
Effect of melatonin supplementation on endothelial function in heart failure with reduced ejection fraction: A randomized, double-blinded clinical trial.
Topics: Dietary Supplements; Double-Blind Method; Female; Heart Failure; Humans; Male; Melatonin; Middle Age | 2021 |
[Effectiveness of metabolic preparations in complex treatment of elderly patients with postinfarction cardiosclerosis and circulatory insufficiency].
Topics: Administration, Oral; Administration, Sublingual; Adrenergic beta-Antagonists; Aged; Amino Acids; An | 2005 |
20 other studies available for melatonin and Cardiac Failure
| Article | Year |
|---|---|
The circadian clock remains intact, but with dampened hormonal output in heart failure.
Topics: Animals; Circadian Clocks; Circadian Rhythm; Female; Heart Failure; Humans; Hydrocortisone; Male; Me | 2023 |
Effects of melatonin on cardiac metabolic reprogramming in doxorubicin-induced heart failure rats: A metabolomics study for potential therapeutic targets.
Topics: Animals; Antibiotics, Antineoplastic; Doxorubicin; Heart; Heart Failure; Ketones; Male; Melatonin; M | 2023 |
Heart failure causes sleepless nights.
Topics: Heart Failure; Humans; Melatonin; Pineal Gland; Sleep Disorders, Circadian Rhythm | 2023 |
Melatonin ameliorates pressure overload-induced cardiac hypertrophy by attenuating Atg5-dependent autophagy and activating the Akt/mTOR pathway.
Topics: Animals; Apoptosis; Autophagy; Autophagy-Related Protein 5; Cardiomegaly; Disease Models, Animal; Fi | 2020 |
[Prognostic Value of Melatonin Level, Structural and Functional Changes of the Myocardium in the Development of Complications in Patients With Heart Failure who Underwent Coronary Artery Bypass Grafting: the Possibilities of Pharmacological Cardioprotecti
Topics: Coronary Artery Bypass; Heart Failure; Humans; Melatonin; Myocardium; Postoperative Complications; P | 2017 |
Effect of Melatonin on Rat Heart Mitochondria in Acute Heart Failure in Aged Rats.
Topics: 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase; Aging; Animals; Calcium; Cell Respiration; Cryoultrami | 2018 |
Melatonin improves cardiac function in a mouse model of heart failure with preserved ejection fraction.
Topics: Adipokines; Animals; Antioxidants; Apoptosis; Diet, High-Fat; Disease Models, Animal; Heart Failure; | 2018 |
Melatonin protects against ischemic heart failure in rats.
Topics: Animals; Antioxidants; Disease Models, Animal; Drug Evaluation, Preclinical; Heart; Heart Failure; M | 2013 |
Alteration in diurnal and nocturnal melatonin serum level in patients with chronic heart failure.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; Circadian Rhythm; Heart Failure; Humans; Melatonin; Mid | 2013 |
[Structural reorganization of the myocardium in ovariectomized rats with experimental heart failure after melatonin administration].
Topics: Animals; Apoptosis; Female; Heart; Heart Failure; Heart Ventricles; Humans; Melatonin; Myocardium; M | 2013 |
The potential usefulness of serum melatonin level to predict heart failure in patients with hypertensive cardiomyopathy.
Topics: Cardiomyopathies; Female; Heart Failure; Humans; Hypertension; Male; Melatonin; Middle Aged; Predict | 2014 |
Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure.
Topics: Animals; Cardiomegaly; Heart Failure; Isoproterenol; Male; Melatonin; Rats; Rats, Wistar | 2014 |
[Extracellular matrix remodeling myocardium of the left ventricle rats with experimental heart failure after perindopril and melatonin administration].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Disease Models, Animal; Extracellul | 2014 |
Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony.
Topics: Aged; Cardiac Resynchronization Therapy; Echocardiography; Female; Follow-Up Studies; Heart Atria; H | 2016 |
[Encapsulation of atrial natriuretic peptide (ANP) cDNA transfection cells and ANP circadian expression].
Topics: Animals; Atrial Natriuretic Factor; Caproates; CHO Cells; Circadian Rhythm; Cricetinae; Drug Deliver | 2003 |
Low urinary 6-sulfatoxymelatonin levels in patients with severe congestive heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Benzodiazepines; Female; H | 2003 |
Decreased sleep in heart failure: are medications to blame?
Topics: Adrenergic beta-Antagonists; Heart Failure; Humans; Melatonin; Sleep Initiation and Maintenance Diso | 2007 |
The pineal affects life span in hamsters with heart disease.
Topics: Animals; Cardiomyopathies; Circadian Rhythm; Cricetinae; Heart Failure; Longevity; Male; Melatonin; | 1997 |
Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats.
Topics: Animals; Antibiotics, Antineoplastic; Anticholesteremic Agents; Antioxidants; Doxorubicin; Heart; He | 1998 |
[State of the neurohumoral regulatory system in circulatory insufficiency].
Topics: 17-Ketosteroids; Adult; Aged; Aldosterone; Angiotensinogen; Coronary Disease; Cortisone; Endopeptida | 1976 |